Terje Risberg

2.1k total citations
52 papers, 1.6k citations indexed

About

Terje Risberg is a scholar working on Oncology, Complementary and alternative medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Terje Risberg has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 16 papers in Complementary and alternative medicine and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Terje Risberg's work include Complementary and Alternative Medicine Studies (16 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Palliative Care and End-of-Life Issues (6 papers). Terje Risberg is often cited by papers focused on Complementary and Alternative Medicine Studies (16 papers), Childhood Cancer Survivors' Quality of Life (6 papers) and Palliative Care and End-of-Life Issues (6 papers). Terje Risberg collaborates with scholars based in Norway, United States and United Kingdom. Terje Risberg's co-authors include E. Wist, S. Kaasa, Jan Norum, Erik A. Wist, Eiliv Lund, Tom Wilsgaard, Bjørn Østenstad, Sveinung Wergeland Sørbye, Per Eystein Lønning and Erik Løkkevik and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Terje Risberg

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terje Risberg Norway 23 695 435 345 285 205 52 1.6k
Erik Wist Norway 28 1.3k 1.9× 69 0.2× 383 1.1× 645 2.3× 152 0.7× 59 2.6k
Violante E. Currie United States 25 1.8k 2.6× 137 0.3× 636 1.8× 233 0.8× 59 0.3× 41 2.6k
Matthew P. Mumber United States 10 894 1.3× 322 0.7× 240 0.7× 123 0.4× 62 0.3× 14 1.5k
Megan E. Miller United States 20 366 0.5× 87 0.2× 312 0.9× 89 0.3× 71 0.3× 79 1.3k
Sue Ashley United Kingdom 18 378 0.5× 184 0.4× 91 0.3× 210 0.7× 41 0.2× 27 1.6k
Judith Hurley United States 24 1.1k 1.6× 148 0.3× 646 1.9× 219 0.8× 158 0.8× 74 2.3k
Amanda Townsend Australia 25 1.2k 1.7× 80 0.2× 311 0.9× 656 2.3× 291 1.4× 128 2.4k
Marisa C. Weiss United States 15 929 1.3× 40 0.1× 403 1.2× 363 1.3× 93 0.5× 31 1.9k
Janise M. Roh United States 19 720 1.0× 52 0.1× 141 0.4× 168 0.6× 73 0.4× 80 1.2k
César A. Rodríguez Spain 20 627 0.9× 48 0.1× 372 1.1× 221 0.8× 66 0.3× 73 1.4k

Countries citing papers authored by Terje Risberg

Since Specialization
Citations

This map shows the geographic impact of Terje Risberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terje Risberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terje Risberg more than expected).

Fields of papers citing papers by Terje Risberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terje Risberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terje Risberg. The network helps show where Terje Risberg may publish in the future.

Co-authorship network of co-authors of Terje Risberg

This figure shows the co-authorship network connecting the top 25 collaborators of Terje Risberg. A scholar is included among the top collaborators of Terje Risberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terje Risberg. Terje Risberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frydenberg, Hanne, Inger Thune, E. Mortensen, et al.. (2016). Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival. Breast Cancer Research and Treatment. 155(2). 345–354. 38 indexed citations
2.
Synnestvedt, Marit, Elin Borgen, Erik Wist, et al.. (2012). Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study. BMC Cancer. 12(1). 616–616. 18 indexed citations
3.
Chrisanthar, Ranjan, Stian Knappskog, Erik Løkkevik, et al.. (2011). Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel. PLoS ONE. 6(4). e19249–e19249. 81 indexed citations
4.
Anvik, Tor, Hilde Grimstad, Anders Bærheim, et al.. (2008). Medical students’ cognitive and affective attitudes towards learning and using communication skills – a nationwide cross-sectional study. Medical Teacher. 30(3). 272–279. 61 indexed citations
5.
Anvik, Tor, Tore Gude, Hilde Grimstad, et al.. (2007). Assessing medical students' attitudes towards learning communication skills – which components of attitudes do we measure?. BMC Medical Education. 7(1). 4–4. 47 indexed citations
6.
Geisler, Jürgen, Per Eystein Lønning, Lars Erik Krag, et al.. (2006). Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study. European Journal of Cancer. 42(17). 2968–2975. 84 indexed citations
7.
Norum, Jan, Terje Risberg, & Jan Abel Olsen. (2005). A monoclonal antibody against HER-2 (trastuzumab) for metastatic breast cancer: a model-based cost-effectiveness analysis. Annals of Oncology. 16(6). 909–914. 46 indexed citations
8.
Gude, Tore, Anders Bærheim, Are Holen, et al.. (2005). Comparing self-reported communication skills of medical students in traditional and integrated curricula: A nationwide study. Patient Education and Counseling. 58(3). 271–278. 17 indexed citations
9.
Wist, Erik A., et al.. (2004). Oral capecitabine in anthracycline- and taxane-pretreated advanced/metastatic breast cancer. Acta Oncologica. 43(2). 186–189. 50 indexed citations
10.
Wist, Erik A., et al.. (2004). Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer. Acta Oncologica. 43(1). 11–14. 20 indexed citations
11.
Risberg, Terje, Arne Kolstad, Erik A. Wist, et al.. (2003). [Should alternative therapists treat cancer--what is the opinion of oncology health personnel?].. PubMed. 123(21). 3059–61.
12.
Risberg, Terje, Andrew J. Vickers, Roy M. Bremnes, et al.. (2003). Does use of alternative medicine predict survival from cancer?. European Journal of Cancer. 39(3). 372–377. 56 indexed citations
13.
Lønning, Per Eystein, Björn Erikstein, Anne Irene Hagen, et al.. (2001). The potential for aromatase inhibition in breast cancer prevention.. PubMed. 7(12 Suppl). 4423s–4412s. 6 indexed citations
14.
Risberg, Terje, et al.. (1997). [Use of alternative medicine among Norwegian hospitalized cancer patients].. PubMed. 117(17). 2458–63. 1 indexed citations
15.
Risberg, Terje, et al.. (1997). Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway. European Journal of Cancer. 33(4). 575–580. 50 indexed citations
16.
Risberg, Terje, Roy M. Bremnes, E. Wist, S. Kaasa, & Bjarne K. Jacobsen. (1997). Communicating with and treating cancer patients: How does the use of non-proven therapies and patients' feeling of mental distress influence the interaction between the patient and the hospital staff. European Journal of Cancer. 33(6). 883–890. 13 indexed citations
17.
Risberg, Terje, E. Wist, S. Kaasa, Eiliv Lund, & Jan Norum. (1996). Spiritual healing among Norwegian hospitalised cancer patients and patients' religious needs and preferences of pastoral services. European Journal of Cancer. 32(2). 274–281. 19 indexed citations
18.
Wist, Erik & Terje Risberg. (1993). Topical Capsaicin in Treatment of Hyperalgesia, Allodynia and Dysesthetic Pain Caused by Malignant Tumour Infiltration of the Skin. Acta Oncologica. 32(3). 343–343. 9 indexed citations
19.
Wist, E. & Terje Risberg. (1991). Trofosfamide in Non-Hodgkin's Lymphoma a Phase II Study. Acta Oncologica. 30(7). 819–821. 18 indexed citations
20.
Paus, Elisabeth & Terje Risberg. (1989). Establishment and Evaluation of a Radioimmunoassay for Neuron-Specific Enolase. Tumor Biology. 10(1). 23–30. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik Wist Breakdown of academic impact, for papers by Violante E. Currie Breakdown of academic impact, for papers by Matthew P. Mumber Breakdown of academic impact, for papers by Megan E. Miller Breakdown of academic impact, for papers by Sue Ashley Breakdown of academic impact, for papers by Judith Hurley Breakdown of academic impact, for papers by Amanda Townsend Breakdown of academic impact, for papers by Marisa C. Weiss Breakdown of academic impact, for papers by Janise M. Roh Breakdown of academic impact, for papers by César A. Rodríguez
Rankless by CCL
2026